Activity-dependent enhancement of hyperpolarizing and depolarizing γ-aminobutyric acid (GABA) synaptic responses following inhibition of GABA uptake by tiagabine

Epilepsy Research

Volumn 37, Issue 1, 1999, Pages 25-36

  Jackson, Michael F ^a   Esplin, Barbara ^a   Čapek, Radan ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Anticonvulsant; Evoked isolated inhibitory postsynaptic potentials; GABA; Hippocampus; Tiagabine; Uptake

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; TIAGABINE;

4 AMINOBUTYRIC ACID UPTAKE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIAL; MALE; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SEIZURE;

ANIMALS; ANTICONVULSANTS; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; INTERNEURONS; MALE; NEURAL INHIBITION; NIPECOTIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 0032878369     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(99)00029-7     Document Type: Article

References (51)

1. Alger B.E., Nicoll R.A. Pharmacological evidence for two kinds of GABA receptor on rat hippocampal pyramidal cells studied in vitro. J. Physiol. 328:1982;125-141.
2. Andersen P., Dingledine R., Gjerstad L., Langmoen I.A., Laursen A.M. Two different responses of hippocampal pyramidal cells to application of gamma-aminobutyric acid. J. Physiol. 305:1980;279-296.
3. Avoli M., Psarropoulou C., Tancredi V., Fueta Y. On the synchronous activity induced by 4-aminopyridine in the CA3 subfield of juvenile rat hippocampus. J. Neurophysiol. 70:1993;1018-1029.
4. Ben-Menachem E. International experience with tiagabine add-on therapy. Epilepsia. 36:1995;S14-S21.
5. Blanton M.G., Lo Turco J.J., Kriegstein A.R. Whole-cell recording from neurons in slices of reptilian and mammalian cerebral cortex. J. Neurosci. Methods. 30:1989;203-210.
6. 3H-GABA in nerve terminals of rat cerebral cortex by electron microscopic autoradiography. Nature. 229:1971;628-630.
7. Buhl E.H., Halasy K., Somogyi P. Diverse sources of hippocampal unitary inhibitory postsynaptic potentials and the number of synaptic release sites. Nature. 368:1994;823-828.
8. Čapek R., Esplin B. Frequency-dependent enhancement of hippocampal recurrent inhibition by GABA uptake blockers. Epilepsy Res. 16:1993;123-130.
9. Dalby N.O., Nielsen E.B. Tiagabine exerts an anti-epileptogenic effect in amygdala kindling epileptogenesis in the rat. Neurosci. Lett. 229:1997;135-137.
10. Davies C.H., Davies S.N., Collingridge G.L. Paired-pulse depression of monosynaptic GABA-mediated inhibitory postsynaptic responses in rat hippocampus. J. Physiol. 424:1990;513-531.
11. Decavel C., Van den Pol A.N. GABA: a dominant neurotransmitter in the hypothalamus. J. Comp. Neurol. 302:1990;1019-1037.
12. Faingold C.L., Randall M.E., Anderson C.A.B. Blockade of GABA uptake with tiagabine inhibits audiogenic seizures and reduces neuronal firing in the inferior colliculus of the genetically epilepsy-prone rat. Exp. Neurol. 126:1994;225-232.
13. A receptor-mediated responses in pyramidal cells of rat hippocampus. J. Neurophysiol. 69:1993;1541-1555.
14. Halonen T., Nissinen J., Jansen J.A., Pitkänen A. Tiagabine prevents seizures, neuronal damage and memory impairment in experimental status epilepticus. Eur. J. Pharmacol. 299:1996;69-81.
15. Hu R.Q., Davies J.A. Tiagabine hydrochloride, an inhibitor of gamma-aminobutyric acid (GABA) uptake, induces cortical depolarizations in vitro. Brain Res. 753:1997;260-268.
16. Isaacson J.S., Solís J.M., Nicoll R.A. Local and diffuse synaptic actions of GABA in the hippocampus. Neuron. 10:1993;165-175.
17. Jackson M.F., Esplin B., Čapek R. High-frequency synchronous firing of interneurons increases the effectiveness of GABAergic transmission. Soc. Neurosci. Abstr. 21:1995;983. Abstract No. 388.15.
18. Jackson M.F., Esplin B., Čapek R. Activity-dependent enhancement of inhibitory postsynaptic potentials (IPSPs) by the GABA-uptake inhibitor tiagabine in hippocampal slices. Soc. Neurosci. Abstr. 22:1996;2104. Abstract No. 824.1.
19. A receptor-mediated depolarizing responses (DRs) in hippocampal pyramidal cells. J. Neurophysiol. 81:1999;1192-1198.
20. A receptor channel function in the nervous system. Prog. Neurobiol. 42:1994;489-537.
21. Knowles W.D., Schwartzkroin P.A. Local circuit synaptic interactions in hippocampal brain slices. J. Neurosci. 1:1981;318-322.
22. Lacaille J.-C., Mueller A.L., Kunkel D.D., Schwartzkroin P.A. Local circuit interactions between oriens/alveus interneurons and CA1 pyramidal cells in hippocampal slices: electrophysiology and morphology. J. Neurosci. 7:1987;1979-1993.
23. Lamsa K., Kaila K. Ionic mechanisms of spontaneous GABAergic events in rat hippocampal slices exposed to 4-aminopyridine. J. Neurophysiol. 78:1997;2582-2591.
24. Li X.-G., Somogyi P., Tepper J.M., Buzsáki G. Axonal and dendritic arborization of an intracellularly labeled chandelier cell in the CA1 region of the rat hippocampus. Exp. Brain. Res. 90:1992;519-525.
25. McCarren M., Alger B.E. Use-dependent depression of IPSPs in rat hippocampal pyramidal cells in vitro. J. Neurophysiol. 53:1985;557-571.
26. Miles R., Wong R.K.S. Inhibitory control of local excitatory circuits in the guinea-pig hippocampus. J. Physiol. 388:1987;611-629.
27. Miles R., Tóth K., Gulyás A.I., Hájos N., Freund T.F. Differences between somatic and dendritic inhibition in the hippocampus. Neuron. 16:1996;815-823.
28. Oh D.J., Dichter M.A. Effect of a gamma-aminobutyric acid uptake inhibitor, NNC-711, on spontaneous postsynaptic currents in cultured rat hippocampal neurons: Implications for antiepileptic drug development. Epilepsia. 35:1994;426-430.
29. Olbrich H.-G., Braak H. Ratio of pyramidal cells versus non-pyramidal cells in sector CA1 of the human Ammon's horn. Anat. Embryol. 173:1985;105-110.
30. Perreault P., Avoli M. Physiology and pharmacology of epileptiform activity induced by 4-aminopyridine in rat hippocampal slices. J. Neurophysiol. 65:1991;771-785.
31. Perreault P., Avoli M. 4-Aminopyridine-induced epileptiform activity and a GABA-mediated long-lasting depolarization in the rat hippocampus. J. Neurosci. 12:1992;104-115.
32. Pfeiffer M., Draguhn A., Meierkord H., Heinemann U. Effects of gamma-aminobutyric acid (GABA) agonists and GABA uptake inhibitors on pharmacosensitive and pharmacoresistant epileptiform activity in vitro. Br. J. Pharmacol. 119:1996;569-577.
33. Roepstorff A., Lambert J.D.C. Factors contributing to the decay of the stimulus-evoked IPSC in rat hippocampal CA1 neurons. J. Neurophysiol. 72:1994;2911-2926.
34. Sachdeo R.C., Leroy R.F., Krauss G.L., Drake M.E. Jr., Green P.M., Leppik I.E., Shu V.S., Ringham G.L., Sommerville K.W. Tiagabine therapy for complex partial seizures. A dose-frequency study. The tiagabine study group. Arch. Neurol. 54:1997;595-601.
35. Schachter S.C. Tiagabine monotherapy in the treatment of partial epilepsy. Epilepsia. 36:1995;S2-S6.
36. Schwartzkroin P.A., Mathers L.H. Physiological and morphological identification of a nonpyramidal hippocampal cell type. Brain Res. 157:1978;1-10.
37. Shinnar S. Tiagabine. Semin. Pediatr. Neurol. 4:1997;24-33.
38. Sik A., Penttonen M., Ylinen A., Buzsáki G. Hippocampal CA1 interneurons: an in vivo intracellular labeling study. J. Neurosci. 15:1995;6651-6665.
39. Smith S.E., Parvez N.S., Chapman A.G., Meldrum B.S. The gamma-aminobutyric acid uptake inhibitor, tiagabine, is anticonvulsant in two animal models of epilepsy. Eur. J. Pharmacol. 273:1995;259-265.
40. A receptors. Science. 269:1995;977-981.
41. Suzdak P.D. Lack of tolerance to the anticonvulsant effects of tiagabine following chronic (21 day) treatment. Epilepsy Res. 19:1994;205-213.
42. Théorêt Y., Brown A., Fleming S.P., Čapek R. Hippocampal field potential: a microcomputer aided comparison of amplitude and integral. Brain Res. Bull. 12:1984;589-595.
43. Thompson S.M., Gähwiler B.H. Activity-dependent disinhibition. I. Repetitive stimulation reduces IPSP driving force and conductance in the hippocampus in vitro. J. Neurophysiol. 61:1989;501-511.
44. Thompson S.M., Gähwiler B.H. Effects of the GABA uptake inhibitor tiagabine on inhibitory synaptic potentials in rat hippocampal slice cultures. J. Neurophysiol. 67:1992;1698-1701.
45. Thompson S.M., Fortunato C., McKinney R.A., Müller M., Gähwiler B.H. Mechanisms underlying the neuropathological consequences of epileptic activity in the rat hippocampus in vitro. J. Comp. Neurol. 372(4):1996;515-528.
46. Traub R.D., Miles R., Wong R.K.S. Models of synchronized hippocampal bursts in the presence of inhibition. I. Single population events. J. Neurophysiol. 58:1987;739-751.
47. Traub R.D., Miles R., Wong R.K.S., Schulman L.S., Schneiderman J.H. Models of synchronized hippocampal bursts in the presence of inhibition. II. Ongoing spontaneous population events. J. Neurophysiol. 58:1987;752-764.
48. Traub R.D., Borck C., Colling S.B., Jefferys J.G.R. On the structure of ictal events in vitro. Epilepsia. 37:1996;879-891.
49. Williams S., Samulack D.D., Beaulieu C., Lacaille J.-C. Membrane properties and synaptic responses of interneurons located near the stratum lacunosum-moleculare/radiatum border of area CA1 in whole-cell recordings from rat hippocampal slices. J. Neurophysiol. 71:1994;2217-2235.
50. Woodson W., Nitecka L., Ben-Ari Y. Organization of the GABAergic system in the rat hippocampal formation: a quantitative immunocytochemical study. J. Comp. Neurol. 280:1989;254-271.
51. Xie X., Smart T.G. A physiological role for endogenous zinc in rat hippocampal synaptic neurotransmission. Nature. 349:1991;521-524.